Skip to content

Vericel VCEL Price / book

Price / book at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
1.4×-0.4×
LeMaitre Vascular logo
LeMaitre VascularLMAT
6.1×+0.7×
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
6.3×+2.9×
Globus Medical logo
Globus MedicalGMED
2.5×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on the most recent quarter.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's price / book?
Vericel (VCEL) reported price / book of 4.6× in Q1 2026.
How has Vericel's price / book changed year-over-year?
Vericel's price / book decreased by 39.2% year-over-year, from 7.6× to 4.6×.
What is the long-term trend for Vericel's price / book?
Over 5 years (2020 to 2025), Vericel's price / book has grown at a -13.8% compound annual growth rate (CAGR), from 10.8× to 5.1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.